Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center | Zendy

Ryan Nachwalter | Zendy; Robert J. Rothrock | Zendy; Evangelia Katsoulakis | Zendy; Mrinal M. Gounder | Zendy; Patrick J. Boland | Zendy; Mark H. Bilsky | Zendy; Ilya Laufer | Zendy; Adam M. Schmitt | Zendy; Yoshiya Yamada | Zendy; Daniel S. Higginson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center

Author(s) -

Ryan Nachwalter,

Robert J. Rothrock,

Evangelia Katsoulakis,

Mrinal M. Gounder,

Patrick J. Boland,

Mark H. Bilsky,

Ilya Laufer,

Adam M. Schmitt,

Yoshiya Yamada,

Daniel S. Higginson

Publication year - 2019

Publication title -

journal of neuro-oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.256

H-Index - 114

eISSN - 1573-7373

pISSN - 0167-594X

DOI - 10.1007/s11060-019-03239-3

Subject(s) - medicine , retrospective cohort study , cohort , cancer , survival analysis , radiation therapy , surgery

Dedifferentiated chordomas (DC) are genetically and clinically distinct from conventional chordomas (CC), exhibiting frequent SMARCB1 alterations and a more aggressive clinical course. We compared treatment and outcomes of DC and CC patients in a retrospective cohort study from a single, large-volume cancer center.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research